Welcome to our dedicated page for Vital Farms SEC filings (Ticker: VITL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Vital Farms, Inc. (Nasdaq: VITL) is a Certified B Corporation and Delaware public benefit corporation that focuses on pasture-raised eggs and egg-based foods such as shell eggs, butter, hard-boiled eggs, and liquid whole eggs. As a publicly traded company, Vital Farms files regular reports and current reports with the U.S. Securities and Exchange Commission (SEC), providing detailed information on its financial performance, risks, governance, and strategic initiatives.
On this page, you can review Vital Farms’ SEC filings, including annual reports on Form 10-K and quarterly reports on Form 10-Q, which describe its business model, farm network, product categories, and risk factors related to supply, consumer demand, agricultural disease, regulation, and macroeconomic conditions. These filings also discuss its status as a public benefit corporation, its stakeholder-focused objectives, and its emphasis on humane treatment of farm animals and sustainable farming practices.
Current reports on Form 8-K offer more immediate updates. Recent 8-K filings have covered quarterly financial results, long-term net revenue targets, and governance matters such as the appointment of a new independent director and the frequency of advisory Say-on-Pay votes. An amended 8-K explains the company’s decision to hold non-binding advisory votes on executive compensation annually, following stockholder preferences.
Stock Titan’s platform enhances access to these documents with AI-powered summaries that explain key sections of Vital Farms’ filings in plain language. Investors can quickly understand highlights from lengthy 10-K and 10-Q reports, see what management disclosed in 8-K earnings releases, and track governance items without reading every page. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-generated overviews help readers identify significant changes, recurring themes, and references to long-term targets and capital projects.
For users monitoring insider and governance activity, this page also centralizes access to forms and disclosures related to directors and executive compensation policies as referenced in Vital Farms’ filings.
Vital Farms Inc (Common Stock) — The Vanguard Group filed an amendment to its Schedule 13G/A reporting a reallocation of beneficial‑ownership reporting following an internal realignment. The filing states that, following the realignment referenced to January 12, 2026, certain Vanguard subsidiaries will report separately and The Vanguard Group reports 0 shares beneficially owned and 0% of the class. The filing lists Vanguard's business address as 100 Vanguard Blvd., Malvern, PA and Vital Farms' principal executive office as 3601 South Congress Avenue, Suite C100, Austin, TX, 78704. The amendment is signed by Ashley Grim, Head of Global Fund Administration, dated 03/27/2026.
Vital Farms, Inc. Chief Financial Officer Thilo Wrede reported a routine tax-related share disposition. On March 18, 2026, 3,192 shares of common stock were withheld by the company at $15.70 per share to satisfy withholding tax obligations, rather than being sold in the open market. After this transaction, Wrede directly held 75,477 shares of Vital Farms common stock.
Vital Farms, Inc. executive Kathryn McKeon, CMO and GM, Butter, reported routine tax-related share withholdings. On two March transactions, a total of 2,611 shares of common stock were withheld by the company to satisfy tax obligations, rather than sold on the open market. After these dispositions, she directly holds 49,671 shares of Vital Farms common stock.
Vital Farms, Inc. filed a Form 4 showing that chief legal officer, secretary and head of impact Joanne Bal had company shares withheld to cover tax obligations related to equity compensation. On March 12, 1,586 shares of common stock were withheld at $17.62 per share. On March 16, an additional 1,061 shares were withheld at $17.21 per share. After these tax-withholding dispositions totaling 2,647 shares, Bal directly holds 55,343 shares of Vital Farms common stock.
Vital Farms, Inc. President, CEO & Executive Chair Russell Diez-Canseco reported two routine share dispositions related to tax withholding, not open-market trades. On March 12, 2026, 11,886 shares of common stock were withheld at $17.62 per share. On March 16, 2026, a further 4,798 shares were withheld at $17.21 per share. After these transactions, he directly owned 705,560 shares of Vital Farms common stock.
Vital Farms, Inc. Chief Strategy Officer and President, Eggs, Peter Nicholas Pappas reported routine share dispositions related to taxes, not open-market sales. On two March dates, a total of 2,330 shares of common stock were withheld by the company to satisfy withholding tax obligations, and he continues to hold 81,669 shares directly after these transactions.
Vital Farms, Inc. Chief Financial Officer Thilo Wrede reported a routine tax-related share disposition. On this Form 4, 2,240 shares of common stock were withheld by the company at $17.62 per share to cover withholding tax obligations, and he remains directly holding 78,669 shares afterward.
Vital Farms, Inc. Chief Strategy Officer Stephanie Coon reported routine share dispositions tied to tax obligations rather than market sales. On March 12 and March 16, a total of 2,553 shares of common stock were withheld by the company at prices of $17.62 and $17.21 per share to satisfy withholding tax liabilities. After these tax-withholding transactions, she directly holds 56,419 shares of Vital Farms common stock.
VITL affiliate submitted a Form 144 reporting a proposed sale of 6,500 shares of Common Stock. The shares are described as restricted stock vesting under a registered plan with a broker listed as Morgan Stanley Smith Barney LLC.
The notice shows a transaction date of 03/13/2026 and a filing/processing date of 03/16/2026, and lists NASDAQ as the market. The filing does not state sale proceeds or planned sale timing beyond the dates shown.
VITL notice of proposed sale of 6,760 shares of Common Stock related to restricted stock vesting under a registered plan. The filing shows an aggregate value of $109,579.60 and dates tied to vesting on 03/13/2026 with the filing dated 03/16/2026.